SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tim Gardner who wrote (8996)6/3/1998 10:36:00 AM
From: RealMuLan  Respond to of 23519
 
I think this morning sharp fall has something to do with this Briefing.com piece:

09:19 ET Vivus Inc (VVUS) 8 3/4: Issue indicated 3/4 lower on news sales of company's MUSE urethral suppository have fallen by 2/3 since Viagra was released. In addition, Reuters is reporting that MUSE is ineffective in most men when taken in a clinic and even less useful for those taking the treatment at home, despite a 1997 study that showed it worked in most patients.

Now some more momentum players start to play with this stock. I noticed this stock usually is up before closing, because a lot of shorts do not want to take it back home.



To: Tim Gardner who wrote (8996)6/3/1998 10:37:00 AM
From: RT  Respond to of 23519
 
TIM,

The script numbers will suck come Monday. Last week we had a holiday and script sales will be off at least 25%.
This company makes a good case for MURPHY'S LAW
Everything that can go wrong, will go wrong.

Where is the FDA factory approval? Did the FDA get lost on the way to the factory? All they have to do, is follow the stench.

RT


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News